Composition and method for treating Sjoegren syndrome disease
    32.
    发明授权
    Composition and method for treating Sjoegren syndrome disease 失效
    治疗Sjoegren综合征疾病的组合物和方法

    公开(公告)号:US5340821A

    公开(公告)日:1994-08-23

    申请号:US88304

    申请日:1993-07-07

    摘要: A composition for treating a Sjoegren syndrome disease is disclosed. The composition comprising derivative of spirooxathiolane-quinuclidine of the following formula (I), ##STR1## wherein Z is .dbd.CR.sup.1 R.sup.2, wherein R.sup.1 and R.sup.2 may be the same or different and each represents hydrogen, alkyl, cyclopentyl, cyclohexyl, aryl, diarylmethylol, or alkyl which may be substituted by one or more aryl groups, or an acid addition salt thereof, or an acid addition salt thereof, as an effective component. Especially effective is an administration of a hydrochloric acid addition salt of 2-methylspiro(1,3-oxathiolane-5,3')quinuclidine.

    摘要翻译: 公开了用于治疗Sjoegren综合征疾病的组合物。 该组合物包含下列通式(I)所示的螺硫硫杂环丁烷 - 奎宁环的衍生物,其中Z为= CR 1 R 2,其中R 1和R 2可以相同或不同,各自表示氢,烷基,环戊基,环己基,芳基 ,二芳基羟甲基或可被一个或多个芳基取代的烷基,或其酸加成盐或其酸加成盐作为有效成分。 给予2-甲基螺(1,3-氧硫杂环戊烷-5,3')奎宁环的盐酸加成盐特别有效。

    Secondary antioxidants
    34.
    发明授权
    Secondary antioxidants 失效
    二级抗氧化剂

    公开(公告)号:US4075226A

    公开(公告)日:1978-02-21

    申请号:US777236

    申请日:1977-03-11

    申请人: Charles H. Foster

    发明人: Charles H. Foster

    摘要: Decahydro-3,3,8,8-tetramethoxy-2,7-epithio-1,4-ethanonaphthalene-5,9-dione, decahydro-3,3,8,8-tetraethoxy-2,7-epithio-1,4-ethanonaphthalene-5,9-dione, decahydro-dispiro[1,3-dioxolane-2,3'-(2',7'-epithio-1',4'-ethanonaphthalene)-8',2"-[1,3]dioxolane]-5',9'-dione have been found to be effective as secondary antioxidants for polyolefins.

    摘要翻译: 十氢-3,3,8,8-四甲氧基-2,7-环硫-1,4-亚乙基萘-5,9-d,十氢-3,3,8,8-四乙氧基-2,7-环硫代-1 ,4-乙基萘-5,9-二酮,十氢 - 二氢吡喃并[1,3-二氧戊环-2,3' - (2',7'-表硫基-1',4'-乙基萘)-8',2 已发现“ - [1,3]二氧戊环] -5',9'-二酮作为聚烯烃的二次抗氧化剂是有效的。